Note: Ingredients listed on restricted chemical lists
General Information
Revision date
2017-05-20
Product name
Collagenase Santyl Ointment
CAS No.
8009-03-8
1.2.1 Relevant identified uses
Enzymatic debriding ointment NDC 50484-010-30, & 50484-010-90 DIN 02063670
Icons in SDS
Company Information
company name
Smith & Nephew Inc
Section 2
SECTION 2: Hazards identification
OSHA Regulatory Status Physical state: Semi-solid. Appearance: White to off white, smooth ointment, free from separation Emergency overview: DRAFT The product may cause allergic or sensitivity reaction for individuals sensitive to one or more of the components. OSHA regulatory status: This product is considered not hazardous under 29 CFR 1910.1200 (Hazard Communication).
Principle Routes of Exposure
Ingestion. No allergic sensitivity or toxic reactions have been noted in the recorded clinical investigations. However, one case of systemic manifestation of hypersensitivity to collagenase in a patient treated for more than one year with a combination of collagenase and cortisone has been reported Eyes: May cause eye irritation on direct contact. Skin: The product contains a small amount of sensitizing substances which may provoke an allergic reaction among sensitive individuals in contact with skin. Inhalation: No inhalation hazard under normal conditions. Ingestion: Ingestion may cause irritation and malaise. Target organs: Eyes. Skin.
Environmental effects
Not expected to be harmful to aquatic organisms
